Business
Currency:USD
2023/FY
Stock NameRevenueRatio
Biopharma57.19B97.76%
Other business activities1.31B2.24%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States27.09B46.31%
Emerging Markets12B20.51%
Developed Europe11.65B19.92%
Developed Rest of World4.25B7.27%
Japan3.51B6.00%